HomeNewsBusinessSpiceJet stays afloat on ‘broken wings’ of Boeing 737 MAX

SpiceJet stays afloat on ‘broken wings’ of Boeing 737 MAX

Projected compensation from Boeing for grounded jets helps Indian carrier cushion losses. The airline’s other income in 2020-21 has risen nearly six times on the provision for damages. Over the past two years, the airline has reported Rs 1,232.25 cr as compensation for the grounding of 737 MAX

July 01, 2021 / 13:26 IST
Story continues below Advertisement

Even as COVID-19 hit the Indian civil aviation market, SpiceJet has found a silver lining in other income, which has increased more than six times in 2020-21, compared to 2018-19 and 2017-18.

The airline’s other income in 2020-21 has risen to nearly Rs 9,831 crore as compared to Rs 8,351 crore in 2019-20, Rs 1,490 crore in 2018-19, and Rs 1,312 crore in 2017-18.

Story continues below Advertisement

The reason for this, as the airline itself said in its January-March quarter earnings statement on June 30, is the provision it made for the compensation due from Boeing Corp due to the grounding of Boeing 737 MAX aircraft.

While SpiceJet only had 13 Boeing 737 MAX 8 aircraft flying over Indian skies in March 2019, the airline had already signed an agreement for around 142 more such aircraft, whose deliveries were halted.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show